Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amer Avdagic

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The Journal of Biological Chemistry|November 21, 2018
RORγ regulates the NLRP3 inflammasomeCyrielle Billon, Meghan H Murray, Amer Avdagic, et al.
Journal of Immigrant and Minority Health|August 20, 2017
Cardiovascular Health in St. Louis Bosnian-AmericansMaximillian T Bourdillon, Asad S Akhter, Dejan Vrtikapa, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 22, 2023
A Synthetic ERR Agonist Alleviates Metabolic SyndromeCyrielle Billon, Emmalie Schoepke, Amer Avdagic, et al.
Metabolites|March 24, 2022
Emerging Role of Nuclear Receptors for the Treatment of NAFLD and NASHRyan D Welch, Cyrielle Billon, McKenna Losby, et al.
ACS Chemical Biology|September 8, 2020
A Selective ERRα/γ Inverse Agonist, SLU-PP-1072, Inhibits the Warburg Effect and Induces Apoptosis in Prostate Cancer CellsEmmalie Schoepke, Cyrielle Billon, Keith M Haynes, et al.
Bioorganic & Medicinal Chemistry Letters|December 28, 2018
Development of novel liver X receptor modulators based on a 1,2,4-triazole scaffoldShaimaa S Goher, Kristine Griffett, Lamees Hegazy, et al.
Bioorganic Chemistry|July 20, 2020
Modulation of estrogen-related receptors subtype selectivity: Conversion of an ERRβ/γ selective agonist to ERRα/β/γ pan agonistsMohamed Shahien, Mohamed Elagawany, Sadichha Sitaula, et al.
European Journal of Medicinal Chemistry|July 8, 2023
Development and pharmacological evaluation of a new chemical series of potent pan-ERR agonists, identification of SLU-PP-915Carissa S Hampton, Sadichha Sitaula, Cyrielle Billon, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The Journal of Biological Chemistry|November 21, 2018
RORγ regulates the NLRP3 inflammasomeCyrielle Billon, Meghan H Murray, Amer Avdagic, et al.
Journal of Immigrant and Minority Health|August 20, 2017
Cardiovascular Health in St. Louis Bosnian-AmericansMaximillian T Bourdillon, Asad S Akhter, Dejan Vrtikapa, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 22, 2023
A Synthetic ERR Agonist Alleviates Metabolic SyndromeCyrielle Billon, Emmalie Schoepke, Amer Avdagic, et al.
Metabolites|March 24, 2022
Emerging Role of Nuclear Receptors for the Treatment of NAFLD and NASHRyan D Welch, Cyrielle Billon, McKenna Losby, et al.
ACS Chemical Biology|September 8, 2020
A Selective ERRα/γ Inverse Agonist, SLU-PP-1072, Inhibits the Warburg Effect and Induces Apoptosis in Prostate Cancer CellsEmmalie Schoepke, Cyrielle Billon, Keith M Haynes, et al.
Bioorganic & Medicinal Chemistry Letters|December 28, 2018
Development of novel liver X receptor modulators based on a 1,2,4-triazole scaffoldShaimaa S Goher, Kristine Griffett, Lamees Hegazy, et al.
Bioorganic Chemistry|July 20, 2020
Modulation of estrogen-related receptors subtype selectivity: Conversion of an ERRβ/γ selective agonist to ERRα/β/γ pan agonistsMohamed Shahien, Mohamed Elagawany, Sadichha Sitaula, et al.
European Journal of Medicinal Chemistry|July 8, 2023
Development and pharmacological evaluation of a new chemical series of potent pan-ERR agonists, identification of SLU-PP-915Carissa S Hampton, Sadichha Sitaula, Cyrielle Billon, et al.
Pageof 1